These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12220607)

  • 1. History and current status of opioid maintenance treatments: blending conference session.
    Kreek MJ; Vocci FJ
    J Subst Abuse Treat; 2002 Sep; 23(2):93-105. PubMed ID: 12220607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
    Stimmel B
    J Addict Dis; 2001; 20(4):1-5. PubMed ID: 11760922
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.
    Johnson RE; Chutuape MA; Strain EC; Walsh SL; Stitzer ML; Bigelow GE
    N Engl J Med; 2000 Nov; 343(18):1290-7. PubMed ID: 11058673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.
    Lott DC; Strain EC; Brooner RK; Bigelow GE; Johnson RE
    J Subst Abuse Treat; 2006 Sep; 31(2):187-94. PubMed ID: 16919747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance treatments for opiate -dependent adolescents.
    Minozzi S; Amato L; Bellisario C; Davoli M
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD007210. PubMed ID: 24957634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine.
    Kreek MJ
    Ann N Y Acad Sci; 2000; 909():186-216. PubMed ID: 10911931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone vs. L-alpha-acetylmethadol (LAAM) in the treatment of opiate addiction. A meta-analysis of the randomized, controlled trials.
    Glanz M; Klawansky S; McAullife W; Chalmers T
    Am J Addict; 1997; 6(4):339-49. PubMed ID: 9398932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic treatments for heroin and cocaine dependence.
    Kleber HD
    Am J Addict; 2003; 12(s2):S5-S18. PubMed ID: 12857659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine.
    Ling W; Rawson RA; Compton MA
    J Psychoactive Drugs; 1994; 26(2):119-28. PubMed ID: 7931856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving.
    Lenné MG; Dietze P; Rumbold GR; Redman JR; Triggs TJ
    Drug Alcohol Depend; 2003 Dec; 72(3):271-8. PubMed ID: 14643944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis.
    Farré M; Mas A; Torrens M; Moreno V; Camí J
    Drug Alcohol Depend; 2002 Feb; 65(3):283-90. PubMed ID: 11841899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance treatments for opiate dependent adolescent.
    Minozzi S; Amato L; Davoli M
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007210. PubMed ID: 19370679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical treatment of opioid addiction and dependence.
    Ling W; Rawson RA; Compton M
    Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332
    [No Abstract]   [Full Text] [Related]  

  • 14. A 50-year-old woman addicted to heroin: review of treatment of heroin addiction.
    O'Brien CP
    JAMA; 2008 Jul; 300(3):314-21. PubMed ID: 18594026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.
    Longshore D; Annon J; Anglin MD; Rawson RA
    Addiction; 2005 Aug; 100(8):1131-9. PubMed ID: 16042643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance for opioid addiction with buprenorphine and methadone: "The only thing new in the world is the history you don't know".
    Stimmel B
    J Addict Dis; 2005; 24(3):1-6. PubMed ID: 16186079
    [No Abstract]   [Full Text] [Related]  

  • 17. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2002; (4):CD002207. PubMed ID: 12519569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
    Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP;
    Addiction; 2004 Apr; 99(4):450-60. PubMed ID: 15049745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
    Whitley SD; Kunins HV; Arnsten JH; Gourevitch MN
    J Subst Abuse Treat; 2007 Jul; 33(1):85-90. PubMed ID: 17588493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid dependence treatment, including buprenorphine/naloxone.
    Raisch DW; Fye CL; Boardman KD; Sather MR
    Ann Pharmacother; 2002 Feb; 36(2):312-21. PubMed ID: 11847954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.